Results 201 to 210 of about 49,863 (275)

The influence of pioglitazone on basal gastric acid secretion in omeprazole-treated rats

, 2009
Olena Tsyryuk, Vitaliy Kukharskyy, Tetyana Beregova   +2 more
openalex   +1 more source

E-Gastryal^® + Magnesium Alginate Plus PPI vs. PPI Alone in GERD: Results from the GENYAL^® Randomized Controlled Trial. [PDF]

J Clin Med
Spada C, Salvi D, Pecere S, Mangiola F, Varca S, Rosu S, Prateek V, Ciobanca PV, Goldis A, Barattini DF, Costamagna G.   +10 more
europepmc   +1 more source

Inhibition of metallo-β-lactamases in carbapenem resistant Gram negative bacilli by omeprazole and pantoprazole. [PDF]

Afr Health Sci
Omar EM, Abbas HA, Elsayed MA, Elbaramawi SS, Noureldin NA.   +4 more
europepmc   +1 more source

Combining endoscopic variceal ligation and omeprazole sodium in treating upper gastrointestinal hemorrhage combined with liver cirrhosis. [PDF]

BMC Gastroenterol
Xie C, Gong S, Zhao Z, Liu L, Lu L, Zhou J, Yu X, Xiong Y.   +7 more
europepmc   +1 more source

A systems biology approach to identify key targets in KRAS/BRAF-mutated colorectal cancer. [PDF]

Discov Oncol
Shiravi S, Mottaghi-Dastjerdi N, Shahbazi B, Ahmadi N, Soltany-Rezaee-Rad M, Ghorbani A, Montazeri H.   +6 more
europepmc   +1 more source

Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study

, 2019
Eun Jin Kim, Oh Young Lee, Kang Nyeong Lee, Sung Joon Lee, Jae Young Jang, Jin Woong Cho, Tae-Oh Kim   +6 more
openalex   +2 more sources

Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study. [PDF]

Front Pharmacol
Di J, Yang N, Zhao Y, Chen S, Guo Z, He D, Xiang C, Xiang C.   +7 more
europepmc   +1 more source

Evaluation of the Effect of Formulation Composition and Physicochemical Properties of Omeprazole and Bisoprolol Hemifumarate on Electrospun Nanofibers Characteristics

Justyna Srebro, Ewelina Łyszczarz, Witold Brniak, Dorota Majda, Aleksander Mendyk   +4 more
openalex   +2 more sources

PGS11 USING A COST-UTILITY ANALYSIS FOR ASSESSING SENSITIVITY IN DRUG PRICES OF ESOMEPRAZOLE VERSUS OMEPRAZOLE IN THE ACUTE TREATMENT OF REFLUX OESOPHAGITIS IN THE UK

, 2003
P Wahlqvist
openalex   +1 more source

Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data. [PDF]

Fundam Clin Pharmacol
Santi Laurini G, Nikitina V, Montanaro N, Motola D.   +3 more
europepmc   +1 more source